Testosterone implants added to MIMS

Testosterone implants now listed in MIMS | SPL
Testosterone implants now listed in MIMS | SPL

Testosterone subcutaneous implants are now listed in MIMS.

The 100mg and 200mg implants are indicated for primary and secondary hypogonadism in males. Implants should be inserted into an area where there is relatively little movement or blood supply, such as the lower abdominal wall or buttock.

The recommended dose is 100-600mg. In most hypogonadal men a dose of 600mg maintains plasma testosterone levels within the normal physiological range for 4–5 months.

View Testosterone Implant drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases